Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications
暂无分享,去创建一个
G. Dranitsaris | T. Crook | E. Hatzimichael | L. Benetatos | L. Lattanzio | E. Briasoulis | C. Nigro | Valentinos Kounnis | A. Dasoula | A. Papoudou-Bai | V. Kounnis | C. L. Nigro